Zhen Lei, Wang Xiao, Li Wei, Shi Shutian, Zhao Xuedong, Ai Hui, Que Bin, Wang Mei, Wang Chunmei, Li Qingxiang, Li Zhanquan, Li Tianchang, Wang Lefeng, Jiang Xuejun, Liu Qing, Nie Shaoping
Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Medical Research & Biometrics Center, National Center for Cardiovascular Diseases, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Cardiovasc Diagn Ther. 2023 Aug 31;13(4):650-659. doi: 10.21037/cdt-22-542. Epub 2023 Jul 25.
The accurate placement of stents for treatment of coronary aorto-ostial lesions (AOLs) is technically challenging. The purpose of this study was to evaluate the efficacy and safety of a stent positioning system with a dedicated nitinol device and compare them with those of the conventional approach for stenting of coronary AOLs.
In this prospective, multi-center, open-label, randomized study, conducted from November 2015 to April 2019, patients with coronary AOLs that underwent percutaneous coronary intervention (PCI) were randomly allocated (allocation ratio 1:1) using block randomization method to either a stent positioning system group or a conventional technique group. The primary endpoint was the range of stent slippage when positioning. The following secondary endpoints were applied: (I) the extent of swing of the guiding catheters during stent positioning; (II) the rate of accurate stent placement; (III) the procedure time; and (IV) the incidence of major adverse cardiovascular events (MACEs) including cardiac death, myocardial infarction, target lesion revascularization, and stent thrombosis.
During the study period, 139 patients with aorto-ostial coronary artery stenosis were included at 5 centers. A total of 69 patients were allocated to the stent positioning system group and 70 patients to the conventional technique group. Angiographic and clinical success were achieved in 100% of the patients included in both groups. The range of stent slippage was significantly shorter in the stent positioning system group than it was in the conventional technique group [0.64 (0.22; 1.35) 1.11 (0.48; 1.72) mm, P=0.01]. The rate of accurate placement of stents was higher in the stent positioning system group than it was in the conventional technique group (74.6% 57.1%, P=0.03). The extent of guiding catheter swing during the stent positioning [0.24 (0.19; 0.53) 0.23 (0.19; 0.53) mm; P=0.95] and the MACEs rates (1.4% 2.9%, P>0.99) were similar between the 2 groups. The procedural time of the stent positioning system was longer than that of the conventional approach [1.00 (0.50; 1.50) 0.80 (0.50; 1.50) min, P=0.09].
The dedicated stent positioning system was is safer and provides more accurate placement of stents for coronary AOLs than the conventional approach, and the associated prolongation of procedure time is insignificant.
Chinese Clinical Trial Registry (ChiCTR), Unique identifier: ChiCTR2100053869. URL: https://www.chictr.org.cn/showproj.html?proj=133280.
冠状动脉开口病变(AOL)支架置入术的精确放置在技术上具有挑战性。本研究旨在评估一种带有专用镍钛诺装置的支架定位系统的有效性和安全性,并将其与冠状动脉AOL支架置入术的传统方法进行比较。
在这项于2015年11月至2019年4月进行的前瞻性、多中心、开放标签、随机研究中,对接受经皮冠状动脉介入治疗(PCI)的冠状动脉AOL患者采用区组随机化方法随机分配(分配比例1:1)至支架定位系统组或传统技术组。主要终点是定位时支架滑动的范围。应用以下次要终点:(I)支架定位期间引导导管的摆动程度;(II)支架准确放置率;(III)手术时间;(IV)包括心源性死亡、心肌梗死、靶病变血运重建和支架血栓形成在内的主要不良心血管事件(MACE)的发生率。
在研究期间,5个中心纳入了139例冠状动脉开口狭窄患者。总共69例患者被分配到支架定位系统组,70例患者被分配到传统技术组。两组纳入的患者均100%实现了血管造影和临床成功。支架定位系统组的支架滑动范围明显短于传统技术组[0.64(0.22;1.35)对1.11(0.48;1.72)mm,P = 0.01]。支架定位系统组的支架准确放置率高于传统技术组(74.6%对57.1%,P = 0.03)。两组之间支架定位期间引导导管的摆动程度[0.24(0.19;0.53)对0.23(0.19;0.53)mm;P = 0.95]和MACE发生率(1.4%对2.9%,P>0.99)相似。支架定位系统的手术时间比传统方法长[1.00(0.50;1.50)对0.80(0.50;1.50)分钟,P = 0.09]。
专用支架定位系统比传统方法更安全,能为冠状动脉AOL提供更准确的支架放置,且相关的手术时间延长不显著。
中国临床试验注册中心(ChiCTR),唯一标识符:ChiCTR2100053869。网址:https://www.chictr.org.cn/showproj.html?proj=133280。